FDA expands approval for GSK’s RSV vaccine to cover younger at-risk adults
Posted:
The Food and Drug Administration expanded the approval for GSK’s vaccine to protect against respiratory syncytial virus, or RSV, authorizing its use for at-risk adults as young as 50.
1 Day to Go!
AI In Healthcare: A Virtual Course
With Professor Shafi Ahmed & Dr Kim Oosthuizen
22 May 2025 | 09:30–16:30 (BST)
Earn 8 CPD points
Time is running out!
Tomorrow, we’re diving into how Artificial Intelligence is…
Biostate AI, a leading innovator in artificial intelligence and RNA sequencing, announced the successful completion of a $12M Series A funding round, led by Accel. The company’s immediate focus is revolutionizing RNAseq accessibility and developing clinically relevant predictive models.
Read more here.
Attendees
Sponsors and Exhibitors
AI In Healthcare: A Virtual Course
Contact us